欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
GCN2-IN-6_2183470-09-7_产品详情
2183470-09-7
  • names:

    GCN2-IN-6

  • CAS号:

    2183470-09-7

    MDL Number:
  • MF(分子式): C19H12Cl2F2N4O3S MW(分子量): 485.29
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
GCN2-IN-6
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM002432-250mg 250mg ¥ 0.00 ¥ 0.00 Backorder
- +
¥ 0.00
YZM002432-100mg 100mg >97% ¥ 0.00 ¥ 0.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 2183470-09-7
Inchi
InchiKey
分子式 Formula C19H12Cl2F2N4O3S
分子量 Molecular Weight 485.29
溶解度Solubility
性状
储藏条件 Storage conditions 请根据产品建议的存储条件进行存储,Please store the product under the recommended condition sin the description.
GCN2-IN-6(CAS:2183470-09-7)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 GCN2-IN-6 (Compound 6d) 是一种有效的口服GCN2抑制剂,通过酶法 (IC50为 1.8 nM) 和细胞分析 (IC50为 9.3 nM) 证实
IntroductionGCN2N (Compound 6d) is a potent, and orally availableGCN2inhibitor confirmed by inouse enzymatic (IC50of 1.8 nM) and cellular assays (IC50of 9.3 nM). GCN2N is also a eIF2α kinasePERKinhibitor with anIC50of 0.26 nM (in enzymatic assay) and 230 nM (in cells).
Application1
Application2
Application3
GCN2-IN-6 (Compound 6d) 是一种有效的口服GCN2抑制剂,通过酶法 (IC50为 1.8 nM) 和细胞分析 (IC50为 9.3 nM) 证实。GCN2-IN-6 还为 eIF2α 激酶PERK抑制剂,IC50为 0.26 nM (酶法测定) 和 230 nM (细胞测定)。GCN2-IN-6 (Compound 6d) is a potent, and orally availableGCN2inhibitor confirmed by in-house enzymatic (IC50of 1.8 nM) and cellular assays (IC50of 9.3 nM). GCN2-IN-6 is also a eIF2α kinasePERKinhibitor with anIC50of 0.26 nM (in enzymatic assay) and 230 nM (in cells)[1].
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Fujimoto J, et al. Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding Mode. ACS Med Chem Lett. 2019 Sep 19;10(10):1498-1503.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents